Search results for "Pulmonary toxicity"

showing 5 items of 5 documents

Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.

2005

Lung is a target organ for the toxicity of inhalated compounds. The respiratory tract is frequently exposed to elevated concentrations of these compounds and become the primary target site for toxicity. Occupational, accidental or prolonged exposure to a great variety of chemicals may result in acute or delayed injury to cells of the respiratory tract. Nevertheless, lung has a significant capability of biotransforming such compounds with the aim of reducing its potential toxicity. In some instances, the biotransformation of a given compound can result in the generation of more reactive, and frequently more toxic, metabolites. Indeed, lung tissue is known to activate pro-carcinogens (i.e. po…

Pulmonary toxicityBiologyToxicologyModels BiologicalPathology and Forensic MedicineCell LineXenobioticsCytochrome P-450 Enzyme SystemmedicineHumansEpoxide hydrolaseLungBiotransformationA549 cellAir PollutantsLungCytochrome P450Cell BiologyGeneral Medicinerespiratory systemCYP2E1medicine.anatomical_structureBiochemistryCell cultureToxicitybiology.proteinExperimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie
researchProduct

Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.

2014

BACKGROUND: Colorectal cancer is the third most commonly diagnosed cancer worldwide, with up to 25% of patients presenting with metastases at the time of diagnosis. Despite pulmonary metastasectomy many patients go on to develop pulmonary recurrence, which might be linked to the presence of lung micrometastases. In this setting, the adjuvant administration of high-dose chemotherapy by isolated lung perfusion (ILP) has shown encouraging results. However, the tolerance to and efficacy of modern gemcitabine (GEM)-based chemotherapy regimens during adjuvant ILP remain unknown. We conducted a dose-escalating preclinical study to evaluate the immediate and delayed toxicity of GEM in a pig model t…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAntimetabolites AntineoplasticLung Neoplasmsendocrine system diseasesPulmonary toxicityIsolated lung perfusionmedicine.medical_treatmentAcute Lung InjurySus scrofaDrug Evaluation PreclinicalAnesthesia GeneralGastroenterologyDeoxycytidineInternal medicinemedicineAnimalsLungChemotherapyLungDose-Response Relationship Drugbusiness.industryGeneral MedicineChemotherapy regimenGemcitabineGemcitabineDisease Models Animalmedicine.anatomical_structureAnesthesiaChemotherapy Cancer Regional PerfusionToxicityAcute DiseaseSurgeryFemaleMetastasectomyCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Amiodarone pulmonary toxicity

2004

The amount of literature on amiodarone pulmonary toxicity (APT) peaked in 1983-1984 with several hundred cases reported cumulatively, and declined thereafter. Since the mid-1990s, publications have increased, which suggests that APT remains a current problem in clinical practice. Amiodarone remains difficult to diagnose noninvasively, and although the outcome is good in the majority of patients, not all cases of APT can be controlled satisfactorily.

Pulmonary and Respiratory Medicinemedicine.diagnostic_testbusiness.industryPulmonary toxicityIatrogenic DiseaseAmiodaronePneumoniaAmiodaroneBronchoalveolar LavageRespiratory Function TestsClinical PracticeBronchoalveolar lavageAnesthesiaIatrogenic diseaseHumansPleuraMedicinebusinessAnti-Arrhythmia AgentsLungmedicine.drugClinics in Chest Medicine
researchProduct

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma

2003

BACKGROUND. The acknowledged effectiveness of vinblastine, bleomycin, and methotrexate (VBM) chemotherapy in patients with early-stage Hodgkin lymphoma has been associated with conflicting toxicity reports. METHODS. One hundred forty-three patients were evaluated clinically and had favorable Stage IA or IIA Hodgkin lymphoma. Ninety-three patients were treated with the standard VBM schedule combined with extended-field radiotherapy (EFRT), leaving the choice of the therapeutic sequence free. Fifty subsequent patients were treated with a slightly modified VBM schedule (VbMp) combined with RT limited to involved fields (IF-RT) and delivered only after the end of chemotherapy. In the VbMp sched…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentPulmonary toxicitymedicine.drug_classmedicine.medical_treatmentchemotherapyBleomycinGastroenterologyAntimetaboliteBleomycinchemistry.chemical_compoundHodgkinPrednisoneInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLungradiotherapyAgedChemotherapybusiness.industryHodgkin; chemotherapy; radiotherapy; toxicitytoxicityMiddle AgedCombined Modality TherapyHodgkin DiseaseSurgeryVinblastineRegimenMethotrexateTreatment OutcomeOncologychemistryVincristineFemaleMethotrexateNeoplasm Recurrence Localbusinessmedicine.drugCancer
researchProduct

Use of the Cultex® Radial Flow System as an in vitro exposure method to assess acute pulmonary toxicity of fine dusts and nanoparticles with special …

2013

Exposure of the respiratory tract to airborne particles (including metal-dusts and nano-particles) is considered as a serious health hazard. For a wide range of substances basic knowledge about the toxic properties and the underlying pathomechanisms is lacking or even completely missing. Legislation demands the toxicological characterization of all chemicals placed on the market until 2018 (REACH). As toxicological in vivo data are rare with regard to acute lung toxicity or exhibit distinct limitations (e.g. inter-species differences) and legislation claims the reduction of animal experiments in general ("3R" principle), profound in vitro models have to be established and characterized to m…

Cell SurvivalPulmonary toxicityMetal NanoparticlesToxicologyRisk AssessmentCell LineToxicologyBasic knowledgeToxicity Tests AcuteHumansMedicineInter-laboratoryInhalation ExposureReproducibilityLung toxicitybusiness.industryReproducibility of ResultsIn vitro exposureDustGeneral MedicineCritical parameterAlveolar Epithelial CellsParticulate MatterRadial flowBiochemical engineeringbusinessChemico-Biological Interactions
researchProduct